Nomura Asset Management CO LTD Agios Pharmaceuticals, Inc. Transaction History

Nomura Asset Management CO LTD

10 transactions

Quarter	Operation	Price Per share	shares change
Q4 2019 Feb 13, 2020	SELL	$30.08 - $50.59 $0 - $0	0 Closed
Q3 2019 Nov 13, 2019	BUY	$32.4 - $49.58 $0 - $0	0 New
Q2 2019 Aug 13, 2019	BUY	$46.17 - $68.1 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$45.92 - $67.67 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$45.92 - $67.67 $0 - $0	0 New
Q4 2018 Feb 12, 2019	BUY	$42.73 - $76.53 $0 - $0	0 New
Q3 2018 Nov 07, 2018	BUY	$71.67 - $91.95 $0 - $0	0 New
Q2 2018 Aug 03, 2018	BUY	$73.22 - $99.55 $0 - $0	0 New
Q1 2018 May 14, 2018	BUY	$59.83 - $86.53 $0 - $0	0 New
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $0 - $0	0

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.